An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.
about
Biomimetic and synthetic interfaces to tune immune responsesLinking form to function: Biophysical aspects of artificial antigen presenting cell designNanoengineering approaches to the design of artificial antigen-presenting cellsImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionTowards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.The dendritic cell cytoskeleton promotes T cell adhesion and activation by constraining ICAM-1 mobilityTransgenic Eimeria mitis expressing chicken interleukin 2 stimulated higher cellular immune response in chickens compared with the wild-type parasites.Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Biomaterial Strategies for Immunomodulation.Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor ImmunityEmerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Engineering nano- and microparticles to tune immunityParticle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsCovalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasiaEngaging adaptive immunity with biomaterialsBiomimetic particles as therapeutics.Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.Micro and Nano Material Carriers for Immunomodulation.Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.Antibody-targeted nanoparticles for cancer treatment.Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.T cell immunoengineering with advanced biomaterials.Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Surface engineering for lymphocyte programming.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)An in silico analysis of nanoparticle/cell diffusive transfer: application to nano-artificial antigen-presenting cell:T-cell interaction.Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activationDiffusive transfer between two intensely interacting cells with limited surface kinetics.Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T-Cells.Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.Artificial Antigen-Presenting Cells for Immunotherapies.Nanoscale artificial antigen presenting cells for cancer immunotherapy.A carbon nanotube-polymer composite for T-cell therapy.The right touch: design of artificial antigen-presenting cells to stimulate the immune system
P2860
Q26801229-290BA474-845E-4B5A-BF12-3ACBE8D31233Q27002652-D4851C30-949B-4493-9D96-E5AC466DBB3BQ27023634-188751AE-5E12-4BB3-8087-2AC26755B5DAQ28068378-66D619FE-9411-442C-8931-4601C0325CB6Q28080720-AB7CA766-AB0B-4945-B005-9BE0C37728DFQ34428078-6C64ED36-8320-404A-A336-D1C0365A6939Q35094278-D6D71846-FA60-4522-913E-08BA10EE4E7FQ35672493-8CF7F445-BBE2-453A-862C-CAFE114DE125Q36383130-9310CA3A-AD74-4002-9EA1-6958DCD92C4EQ36703124-C7F6CF46-F786-4FB7-BA5B-00330F7CC775Q36884768-F73FE226-B6C4-43EB-9CEA-0D57F7F09565Q36920724-16DFADAE-75D2-4F21-93E3-7C9F4362FF93Q37205125-7202589F-95D8-42D7-B596-6E20B378CB4CQ37515801-7AEADDDD-F4FE-44B9-A8B1-F04BC603201EQ37575912-582C5603-6C41-4B91-B742-FB7296BEE89AQ37691850-483A9A35-928D-4B8E-A515-D85902C92DB4Q38567436-4C0EBBC8-C725-4FE2-9100-D863298EB1BCQ38684217-CF4A8B31-0BEF-4E70-AC0D-DA878D3248C3Q38841904-487072E6-39E8-4BA7-B4EE-B17104EB42C8Q38874906-4ED132F8-F76C-475B-9535-034F1BC01243Q38887307-C1DBEAA0-DEA7-43DC-9815-8F01C7514ACCQ39111861-61E02EEE-9321-4AAF-8230-50EB916FB67AQ39157864-FA55E284-6A9B-4DD5-AD1B-CA386A3B3239Q39382025-29F3AA43-1F19-4455-AA6E-C62A39E75898Q40044791-D00934BB-28F7-40D6-9621-C4381F060D40Q40214162-D5E9E88E-AACE-419A-8335-5C62453014AEQ40617937-1FA02032-2F1C-47A5-B4FC-76135B4445F6Q41477320-D51C352F-5704-4FEB-AAFC-793C48FB9FBEQ41495742-CEF0BDF9-9578-4642-A4F6-B53512D98B9EQ42030065-37E8867B-FEAD-4E88-AFF3-EBB1EBC4FB87Q47189764-1989E44A-92EF-4A2C-98B3-7808E2234FFEQ47730058-A80BDA48-2272-4B8C-8EFB-B67180D1FFB0Q48243270-4770EE0D-2844-4E43-9DF1-64B511F3BA0CQ51021209-530BEE01-2240-4BE3-8DBE-8BE530D9839CQ52662884-CC2916E9-A775-447E-98E6-669B9246A9ABQ53482969-E03F8081-0945-4697-B7F4-FCEC610AB575Q58619853-2E3B54D9-CEE6-4791-8330-9EC9FD2915F0
P2860
An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An artificial antigen-presenti ...... ection of the T cell response.
@ast
An artificial antigen-presenti ...... ection of the T cell response.
@en
type
label
An artificial antigen-presenti ...... ection of the T cell response.
@ast
An artificial antigen-presenti ...... ection of the T cell response.
@en
prefLabel
An artificial antigen-presenti ...... ection of the T cell response.
@ast
An artificial antigen-presenti ...... ection of the T cell response.
@en
P2093
P2860
P356
P1476
An artificial antigen-presenti ...... rection of the T cell response
@en
P2093
Erin R Steenblock
Jordan S Pober
Michael Labowsky
Tarek M Fahmy
P2860
P304
34883-34892
P356
10.1074/JBC.M111.276329
P407
P577
2011-08-17T00:00:00Z